Unlock instant, AI-driven research and patent intelligence for your innovation.

A class of mercaptoamide boronic acid derivatives and their use as mbl and/or sbl inhibitors

A methyl compound technology, applied in the field of medicine, can solve the problems of MBL inhibitors that have not yet entered

Active Publication Date: 2021-06-25
SICHUAN UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above-mentioned SBL inhibitors are ineffective against MBL-producing carbapenem-resistant bacteria, so people continue to develop MBL inhibitors in order to obtain drugs against MBL-producing carbapenem-resistant bacteria, but so far there is no MBL inhibitor that has entered the clinic. agent
In addition, because the structures and catalytic mechanisms of MBL and SBL are different, and MBL / SBL co-expressing carbapenem-resistant bacteria have only emerged and spread in recent years, few compounds as MBL / SBL dual inhibitors have been reported so far.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A class of mercaptoamide boronic acid derivatives and their use as mbl and/or sbl inhibitors
  • A class of mercaptoamide boronic acid derivatives and their use as mbl and/or sbl inhibitors
  • A class of mercaptoamide boronic acid derivatives and their use as mbl and/or sbl inhibitors

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0061] The following is the preparation of intermediate compounds:

[0062] 1. Intermediate compound A: 1-aminomethylboronic acid pinacol ester hydrochloride

[0063]

[0064] Step 1: Synthesis of bromomethylboronic acid pinacol ester (A-2)

[0065]Compound A-1 triisopropyl borate (10 g, 55 mmol) and dibromomethane (4.2 mL, 60 mmol) were dissolved in dry tetrahydrofuran solution, and pre-cooled at -78°C for 20 minutes. A 2.5M n-butyllithium solution in n-hexane (20 mL, 50 mmol) was slowly dropped into the reaction solution, and stirring was continued at -78°C for 2 hours. The reaction was warmed up to 0°C, methanesulfonic acid (3.2 mL, 50 mmol) was slowly added dropwise, then warmed up to room temperature and stirred for 1 hour. The reaction temperature was lowered to 0° C., pinacol (5.9 g, 50 mmol) was added, and then the temperature was raised to room temperature and stirred for 1 hour. Stop the reaction, spin to remove the solvent, and distill under reduced pressure (...

Embodiment 1

[0142] Example 1: (S)-1-(3'-mercapto-2'-methylpropionamido)methylboronic acid (1)

[0143]

[0144] Step 1: Synthesis of (S)-1-(3'-acetylmercapto-2'-methylpropionamido)methylboronic acid pinacol ester

[0145] Dissolve intermediate compound A (193mg, 1mmol), (S)-3-acetylmercapto-2-methylpropionic acid (162mg, 1mmol) in DMF (10mL), pre-cool at -10°C for 20 minutes, add TBTU (385mg, 1.5mmol) and DIPEA (387mg, 3mmol), the reaction was continued at -10°C for 2 hours. The progress of the reaction was monitored by TLC. After the reaction was complete, an appropriate amount of water was added, extracted several times with ethyl acetate, the combined organic layer was washed twice with saturated brine, dried over anhydrous sodium sulfate, concentrated under reduced pressure, and purified by silica gel column chromatography (eluent is CH 2 Cl 2 / MeOH=100:1) to obtain 212 mg of the product as a colorless oil, with a yield of 74%. 1 H-NMR (400MHz, CDCl 3 ):δ1.23(d,3H,J=6.8Hz),1.2...

Embodiment 2

[0148] Example 2: 1-(3'-mercaptopropionamido)methylboronic acid (2)

[0149]

[0150] Using the intermediate compound A as the starting material, the (S)-3-acetylmercapto-2-methylpropionic acid used in step 1 was replaced by 3-acetylmercaptopropionic acid by the synthetic method of compound 1, and the same Compound 2 can be obtained through the synthetic steps. Colorless oil. 1 H-NMR (400MHz, CDCl 3 ): δ0.84(t, 3H, J=7.2Hz), 1.54(m, 2H), 2.14(t, 2H, J=7.2Hz), 2.36(s, 2H). 13 C-NMR (100MHz, CDCl 3 ): δ13.65, 18.65, 36.82, 41.28, 176.80. MS(ESI+): 146.0[M+H-H 2 O].

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides the compound represented by formula (I), or its conformational isomer, or its optical isomer, or its pharmaceutically acceptable salt. The compound represented by the formula (I) of the present invention has good and broad-spectrum inhibitory activity on MBL and / or SBL enzymes, and can be used to prepare inhibitors of MBL and / or SBL enzymes. And, the compound of the present invention has excellent antibacterial activity to multiple drug-resistant bacteria, can reverse the drug resistance of carbapenem-resistant bacteria, and the antibacterial effect is better than the positive control products L-captopril, tazoba Tan. The compound of the invention has great potential in preparing MBL / SBL dual inhibitors and drugs for reversing drug resistance of carbapenem drug-resistant bacteria.

Description

technical field [0001] The invention belongs to the field of medicine, in particular, the invention relates to a class of mercaptoamide boronic acid derivatives and their use as metallo-beta-lactamase (MBL) and / or serine beta-lactamase (SBL) inhibitors use. Background technique [0002] β-lactam antibiotics, such as penicillins, cephalosporins, carbapenems, etc., are currently the most widely used antibiotics in clinical practice; among them, carbapenem antibiotics have the broadest antibacterial spectrum and the strongest bactericidal ability The β-lactam antibiotic is an important drug for the clinical treatment of infections in severe and immunocompromised patients, and is known as the "last line of defense" against bacteria. However, the current situation of β-lactam antibiotic resistance is very serious. In February 2017, the World Health Organization listed carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae as the most danger...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F5/02C07C323/60A61P31/04A61K31/69A61K31/198
CPCA61P31/04C07B2200/07C07C323/60C07F5/025Y02A50/30
Inventor 李国菠吴勇王耀羚刘莎于竹君颜宇航黄梦怡
Owner SICHUAN UNIV